Related Experiment Video

Updated: Sep 29, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

The jaundiced newborn. Understanding and managing transitional hyperbilirubinemia

D K Stevenson1, R J Wong, S R Hintz

  • 1Division of Neonatal, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. dstevenson@stanford.edu

Minerva Pediatrica
|September 24, 2002
PubMed

Insights

Neonatal jaundice, a common infant condition, involves bilirubin imbalance. Early recognition and management of hyperbilirubinemia are crucial to prevent kernicterus.

Area of Science:

  • Pediatrics
  • Neonatology
  • Biochemistry

Background:

  • Neonatal jaundice is a frequent diagnosis in newborns.
  • It results from an imbalance between bilirubin production and elimination.
  • Pathophysiological conditions can worsen this imbalance, increasing risks.

Purpose of the Study:

  • To review risk factors for neonatal hyperbilirubinemia.
  • To describe diagnostic strategies for transitional hyperbilirubinemia.
  • To outline management approaches for neonatal jaundice.

Main Methods:

  • Literature review of neonatal jaundice.
  • Analysis of pathophysiological mechanisms of hyperbilirubinemia.
  • Synthesis of diagnostic and management guidelines.

Main Results:

  • Identified risk factors contributing to increased bilirubin levels.
  • Described diagnostic criteria for assessing jaundice severity.
  • Outlined therapeutic interventions for hyperbilirubinemia.

Conclusions:

  • Early identification of neonatal jaundice risk factors is essential.
  • Effective management strategies can prevent severe hyperbilirubinemia and kernicterus.
  • Understanding bilirubin metabolism is key to neonatal care.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...